SFRP4 and adenomyosis: Aberrant activation of the Wnt/β-catenin signaling pathway is closely associated with the development of adenomyosis, so the role of SFRP4 in adenomyosis may be similar to that in gastric cancer, activating the Wnt signaling pathway and promoting cell proliferation, invasion, and metastasis (Fig. 4B).